Physician Trainees’ Interactions with the Pharmaceutical Industry (Reply)

Austad KE, Avorn J, Franklin JM, Kesselheim AS - Journal of General Internal Medicine

  • Regulation and Clinical Evidence

Summary:

In this reply, the authors clarify that their finding should not diminish the importance of institutional policies on industry interactions. They emphasize that meaningful enforcement of such policies remains essential and that further research is needed to identify the most effective interventions.

VIEW SOURCE

Recent Work from PORTAL

Talk bubble graphics representing commentary and opinion.

How Congress Can Fix Expert Advisory Committees

Daval CJR, Kesselheim AS - STAT

  • Regulation and Clinical Evidence
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

International Regulatory Status and Reimbursement Recommendations of Haematological Malignancy Drugs Withdrawn from the FDA Accelerated Approval Pathway

Mulsant SS, Kesselheim AS, Naci H - Journal of Cancer Policy

  • Price, Value, and Access
  • Regulation and Clinical Evidence
Talk bubble graphics representing commentary and opinion.

Politics and the Patient Encounter, in Dire Times

Avorn J - MedPage Today

  • Regulation and Clinical Evidence